(Q46334628)

21 December 2017

title

Repeated dosing of digoxin-fragmented antibody in preterm eclampsia (English)

1 reference

21 December 2017

0 references

0 references

0 references

C D Adair

1

1 reference

21 December 2017

V M Buckalew

2

1 reference

21 December 2017

J Kipikasa

3

1 reference

21 December 2017

C Torres

4

1 reference

21 December 2017

S P Stallings

5

1 reference

21 December 2017

C M Briery

6

1 reference

21 December 2017

publication date

1 February 2009

1 reference

21 December 2017

published in

Journal of Perinatology

1 reference

21 December 2017

volume

29

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

163-165

1 reference

21 December 2017

Diagnosis, prevention, and management of eclampsia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

Antidigoxin antibodies in eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

Sodium regulation, sodium pump function and sodium pump inhibitors in uncomplicated pregnancy and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

Sodium transport inhibitors in pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

A protocol for managing severe preeclampsia in the second trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

7 January 2021

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

7 January 2021

Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

7 January 2021

Digoxin-like immunoreactive substance and sodium-potassium-adenosine triphosphatase inhibition in normal pregnancy: a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

7 January 2021

A digoxin-like immunoreactive substance in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

7 January 2021

Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJP.2008.181

7 January 2021

Identifiers

DOI

10.1038/JP.2008.181

1 reference

21 December 2017

Dimensions Publication ID

1001499336

0 references

1 reference

21 December 2017